A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

Altered vaginal flora may also lead to development of bacterial vaginosis (due to Gardenella sp.) Probiotics can help prevent ...

6 This prolonged natural history allows preinvasive cervical lesions to be diagnosed using Pap smear screening programs. These screening programs have significantly decreased the incidence of ...

Cervical cancer screening traditionally relies on the Pap smear and HPV-DNA tests. While effective, these methods are fraught with challenges, including variability in human interpretation, false ...

The review delves into AI's transformative potential in cervical cancer screening, focusing on its role in medical image recognition to identify abnormal cytology and neoplastic lesions.

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.